Allarity Therapeutics, Inc.
ALLR
$1.52
-$0.16-9.52%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.21% | -20.95% | 15.08% | 63.34% | 35.69% |
| Total Depreciation and Amortization | 118.18% | -466.67% | 9.09% | 1,000.00% | -80.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 453.52% | 3.64% | 34.24% | 273.58% | -101.09% |
| Change in Net Operating Assets | -58.70% | 76.14% | -2,195.30% | -103.42% | 221.29% |
| Cash from Operations | 4.90% | 37.79% | -104.06% | 16.22% | 41.10% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -90.04% | -- | -100.00% | 163.12% | -22.01% |
| Repurchase of Common Stock | -243.26% | 94.50% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | 100.00% |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -110.39% | 190.06% | -123.02% | 163.12% | -13.00% |
| Foreign Exchange rate Adjustments | 560.82% | 110.45% | -549.30% | -184.37% | 273.85% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -143.71% | 90.85% | -221.20% | 663.64% | 238.96% |